article Open AccessTop 1% cited

A living WHO guideline on drugs for covid-19 (2020-2023)

BMJ · 2020 · Vol. 370 · pp. m3379–m3379

Arnav Agarwal(Kleijnen Systematic Reviews (United Kingdom))Beverley J. Hunt✉(St Thomas' Hospital)Miriam Stegemann✉(LRS Institute of Tuberculosis and Respiratory Diseases)Bram Rochwerg✉(Kleijnen Systematic Reviews (United Kingdom))François Lamontagne(Université de Sherbrooke)Reed Siemieniuk(Kleijnen Systematic Reviews (United Kingdom))Thomas Agoritsas(Kleijnen Systematic Reviews (United Kingdom))Lisa Askie(Kleijnen Systematic Reviews (United Kingdom))Lyubov Lytvyn(Kleijnen Systematic Reviews (United Kingdom))Yee‐Sin Leo(National Centre for Infectious Diseases)Helen Macdonald(Kleijnen Systematic Reviews (United Kingdom))Linan Zeng(Kleijnen Systematic Reviews (United Kingdom))Ahmed AlhadyanA. MunaWagdy Amin(Ministry of Health and Population)André Ricardo Araújo da Silva(Universidade Federal Fluminense)Diptesh Aryal(Nepal Medical College Teaching Hospital)Fabián Alberto Jaimes BarragánFrédérique Jacquerioz Bausch(University Hospital of Geneva)Erlina Burhan(University of Indonesia)Carolyn S. Calfee(University of California, San Francisco)Maurizio Cecconi(Humanitas University)Binila Chacko(Christian Medical College, Vellore)Duncan Chanda(University Teaching Hospital)Vu Quoc Dat(Hanoi Medical University)An De Sutter(Ghent University)Bin Du(Chinese Academy of Medical Sciences & Peking Union Medical College)Stephen B. Freedman(University of Calgary)Heike Geduld(Western Cape Department of Health)Patrick O. GeeMuhammad Mohsin Haider(Ministry of Public Health)Matthias Götte(University of Alberta)Nerina Harley(The Royal Melbourne Hospital)Madiha Hashmi(Ziauddin University)David S.C. Hui(Chinese University of Hong Kong)Mohamed Ismail(Indira Gandhi Memorial Hospital)Fyezah Jehan(Indira Gandhi Memorial Hospital)Sushil Kumar Kabra(Aga Khan University)Seema Kanda(All India Institute of Medical Sciences)Yae‐Jean Kim(McMaster University)Niranjan Kissoo(Samsung Medical Center)Sanjeev Krishna(University of British Columbia)Krutika Kuppalli(World Health Organization)Arthur Kwizera(St George's, University of London)Marta Lado Castro-Rial(Kleijnen Systematic Reviews (United Kingdom))Thiago Lisboa(Makerere University)Rakesh Lodha(Hospital do Coração)Imelda Mahaka(Hospital do Coração)Hela ManaiMarc MendelsonGiovanni Battista Migliori(University of Cape Town)G Miño(Istituti Clinici Scientifici Maugeri)Emmanuel NsutebuJessica Peter(Sheikh Shakhbout Medical City)Jacobus Preller(Kleijnen Systematic Reviews (United Kingdom))N. PshenichnayaNida Qadir(Central Research Institute of Epidemiology)Shalini Sri Ranganathan(Shanghai Public Health Clinical Center)Pryanka Relan(Kleijnen Systematic Reviews (United Kingdom))Jamie Rylance(Kleijnen Systematic Reviews (United Kingdom))Saniya Sabzwari(University of California, Los Angeles)Rohit Sarin(Aga Khan University)Manu Shankar‐Hari(LRS Institute of Tuberculosis and Respiratory Diseases)Mike Sharland(Guy's and St Thomas' NHS Foundation Trust)Yinzhong ShenJoão Paulo Souza(University of Colombo)Ronald Swanstrom(Universidade de São Paulo)Tshokey Tshokey(Charité - Universitätsmedizin Berlin)Sebastián UgarteTimothy M. Uyeki(Centre for Bhutan Studies and GNH Research)Evangelina Vázquez Curiel(Universidad Andrés Bello)Sridhar Venkatapuram(Centers for Disease Control and Prevention)Dubula Vuyiseka(Centers for Disease Control and Prevention)Ananda Wijewickrama(Lovisenberg Diakonale Høgskole)Lien Tran(Kleijnen Systematic Reviews (United Kingdom))Dena Zeraatkar(Kleijnen Systematic Reviews (United Kingdom))Jessica Bartoszko(Kleijnen Systematic Reviews (United Kingdom))Long Ge(Kleijnen Systematic Reviews (United Kingdom))Romina Brignardello‐Petersen(Kleijnen Systematic Reviews (United Kingdom))Andrew Owen(Universidad Andrés Bello)Gordon Guyatt✉(Kleijnen Systematic Reviews (United Kingdom))Janet Dı́az(Université de Sherbrooke)Letícia Kawano-Dourado(Centers for Disease Control and Prevention)Michael Jacobs(King's College London)Per Olav Vandvik(Kleijnen Systematic Reviews (United Kingdom))

View via DOI Publisher page

Abstract

Recommendations on anticoagulation are planned for the next update to this guideline. Updated data regarding systemic corticosteroids, azithromycin, favipiravir and umefenovir for non-severe illness, and convalescent plasma and statin therapy for severe or critical illness, are planned for review in upcoming guideline iterations.

COVID-19 Clinical Research Studies Health Systems, Economic Evaluations, Quality of Life Pharmaceutical studies and practicesGuidelineRitonavirMedicineRandomized controlled trialContext (archaeology)Coronavirus disease 2019 (COVID-19)Intensive care medicineClinical trialMEDLINEFamily medicine

MeSH terms

BetacoronavirusCOVID-19SARS-CoV-2COVID-19 Drug TreatmentAdrenal Cortex HormonesHumansPneumonia, ViralWorld Health OrganizationCoronavirus InfectionsPandemics